Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Diagnostic Laboratory, |
RCV000148469 | SCV000297176 | uncertain significance | Arrhythmogenic right ventricular cardiomyopathy | 2015-11-30 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000456802 | SCV000551494 | likely benign | Arrhythmogenic right ventricular dysplasia 11 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Department Of Genetics, |
RCV000456802 | SCV000891612 | uncertain significance | Arrhythmogenic right ventricular dysplasia 11 | 2017-12-30 | criteria provided, single submitter | curation | |
Color Diagnostics, |
RCV001180330 | SCV001345234 | uncertain significance | Cardiomyopathy | 2023-05-01 | criteria provided, single submitter | clinical testing | This missense variant replaces serine with leucine at codon 824 of the DSC2 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in two individuals affected with arrhythmogenic right ventricular cardiomyopathy (PMID: 20864495, 24832006). This variant was also detected in a post-mortem heart tissue sample from an individual with clinical diagnosis of arrhythmogenic right ventricular cardiomyopathy (PMID: 24832006). This variant has also been identified in 29/282414 chromosomes (18/24954 African chromosomes) in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV002444604 | SCV002735593 | benign | Cardiovascular phenotype | 2023-04-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV003998167 | SCV004816044 | uncertain significance | Familial isolated arrhythmogenic right ventricular dysplasia | 2024-02-05 | criteria provided, single submitter | clinical testing | This missense variant replaces serine with leucine at codon 824 of the DSC2 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in two individuals affected with arrhythmogenic right ventricular cardiomyopathy (PMID: 20864495, 24832006). This variant was also detected in a post-mortem heart tissue sample from an individual with clinical diagnosis of arrhythmogenic right ventricular cardiomyopathy (PMID: 24832006). This variant has also been identified in 29/282414 chromosomes (18/24954 African chromosomes) in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
CSER _CC_NCGL, |
RCV000148469 | SCV000190169 | uncertain significance | Arrhythmogenic right ventricular cardiomyopathy | 2014-06-01 | no assertion criteria provided | research |